Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.
Disconnection of the hippocampus and amygdala associated with lesion load in relapsing-remitting multiple sclerosis: a structural and functional connectivity study.
Differential Diagnosis for Multiple Sclerosis-related Optic Neuritis.
Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
[Pelvic floor muscles training, electrical stimulation, bladder training and lifestyle interventions to manage lower urinary tract dysfunction in multiple sclerosis: A systematic review].
Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates.
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
[Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"].
Gene expression analysis of histamine receptors in peripheral blood mononuclear cells from individuals with clinically-isolated syndrome and different stages of multiple sclerosis.
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients.
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.
Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.
Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis.
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
Paraneoplastic Neuromyelitis Optica Spectrum Disorders: Three New Cases and A Review of the Literature.
Aryl hydrocarbon receptor-mediated induction of the microRNA-132/212 cluster promotes interleukin-17-producing T-helper cell differentiation.
Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis.
Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.
Multiple Sclerosis International Federation: Stimulating international cooperation in research.
The innate immune system in demyelinating disease.
Community Delivery of a Comprehensive Fall-Prevention Program in People with Multiple Sclerosis: A Retrospective Observational Study.
[Rare case of noeffective therapy with natalizumab (tisabri) in a female patient with multiple sclerosis and neutralizing antibodies to the drug.]
Fingolimod for the treatment of relapsing multiple sclerosis.
Industry Update: The latest developments in therapeutic delivery.
Pages
« first
‹ previous
…
417
418
419
420
421
422
423
424
425
…
next ›
last »